-
About
TOGETHER WITH THE PASQUAL MARAGALL FOUNDATION, WE WORK FOR A FUTURE WITHOUT ALZHEIMER'S
-
Research
INNOVATIVE SOLUTIONS TO UNVEIL AND PREVENT NEURODEGENERATION
-
Services
CUTTING-EDGE FACILITIES AND A TEAM DEVOTED TO RESEARCH
-
Alfa Study
MORE THAN 2.700 DESCENDANTS OF people living with ALZHEIMER'S WILLING TO CHANGE HISTORY
-
Participate
YOU CAN HELP US TO CHANGE THE HISTORY OF THE DISEASE
-
News
STAY INFORMED ABOUT THE LATEST NEWS ON ALZHEIMER'S AND BRAIN RESEARCH
News:Researchers
Read the latest news about Researchers at the Barcelonaβeta Brain Research Center (BBRC).
Raffaele Cacciaglia receives the Ramón y Cajal 2021 grant
The award is a recognition of the trajectory of the researcher, recipient in addition to a Knowledge Generation Project 2021
Outstanding participation of the BBRC in the AAIC 2022 congress
Our research center will have a notable presence at the Alzheimer's Association International Conference (AAIC 2022), which will be held between July 31 and August 4 in San Diego.
A new study shows that alterations in biomarkers are associated with higher volumes of gray matter and an increase in glucose metabolism in the brain in cognitively healthy people
Research helps to better understand the relationship between biomarkers of Alzheimer’s disease and the pathophysiological mechanisms that are altered in their early stages.
We participate in the World Summit on Neurodegenerative Diseases NEURO 2020/2022
During the congress, basic, clinical and translational aspects of research in neurodegenerative diseases were discussed.
Dr. Marta del Campo, appointed Director of the BBRC Fluid Biomarkers Platform
La investigadora tindrà la responsabilitat de desenvolupar, validar i implementar biomarcadors en sang per a la detecció precoç de l’Alzheimer.
Dr. Marc Suárez-Calvet receives the "2021 Alzheimer Award" from the SEN
The award recognizes the leadership, work and key contributions in the field of biochemical biomarkers of the researcher.
The researcher Marta Milà defends the third doctoral thesis done at the BBRC
The thesis develved into urrent knowledge of the disease during its preclinical stage and provides new evidence for its early detection.
Dr. Eider Arenaza-Urquijo, named ISGlobal Associated Researcher
Currently, the BBRC researcher collaborates with ISGlobal in the NCDs (Non-Communicable Diseases) and Environment program on the effects of the pandemic on mental health.
"A titanic effort is being made to understand Alzheimer's disease in its early stages"
Interview with Gemma Salvadó, researcher of the Neuroimaging Group, after obtaining her PhD
